Full article view 2017-09-21T08:01:31+00:00
Back to News & Insights »

Commentary: The Utility of Cancer Value Frameworks for Patients, Payers

Precision’s Chandra and Shafrin Address Value Frameworks in JAMA

Precision Health Economics’ Amitabh Chandra and Jason Shafrin, along with author Ravider Dhawan, examine the utility of cancer value frameworks in the latest edition of the Journal of the American Medical Association (JAMA). To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.